Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INGE-B: Palbociclib in Advanced Breast Cancer
NCT02894398Phase 2Completed
- Sponsor
- iOMEDICO
- Start
- Sep 2016
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by iOMEDICO. Started Sep 2016; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02894398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02894398.